香港股市 已收市

Paragon 28, Inc. (FNA)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
6.15-0.25 (-3.91%)
收市:04:00PM EDT
6.15 0.00 (0.00%)
收市後: 04:05PM EDT

Paragon 28, Inc.

14445 Grasslands Drive
Englewood, CO 80112
United States
855 786 2828
https://paragon28.com

版塊Healthcare
行業Medical Devices
全職員工574

高階主管

名稱頭銜支付行使價出生年份
Mr. Albert DaCostaCo-Founder, Chairman, President & CEO1.4M1974
Ms. Kristina WrightIndependent Interim CFO & Director70k1977
Mr. Robert S. McCormack J.D.General Counsel & Secretary477.53k1968
Mr. Matthew JarboeChief Commercial Officer899.92k1984
Mr. Andrew James HillExecutive Vice President of Research & Development306.06k1984
Mr. Jeff SearsVice President of Operations
Mr. Erik E MickelsonChief Accounting Officer & Controller1982
Matt BrinckmanSenior Vice President of Strategy & Investor Relations
Ms. Michelle MissalVP & Chief Compliance Officer
Mr. John ShumakerExecutive Vice President of Sales - U.S.
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

公司管治

截至 2024年6月1日 止,Paragon 28, Inc. 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中:2;董事會:5;股東權利:5;現金賠償:7。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。